Whats new
Whats new.
Capital One - Exciting HARMONi-2 Data at WCLC Shouldn’t Discount Efti/Pembro Combo in NSCLC; Reiterate OW; $8 PT (Analyst: Naureen Quibria, PhD)
September 11th 2024
For a copy of this research report please contact your Capital One advisor